MedWatch

Ferring pulls the plug on drug hope just before phase 3

Ferring has scrapped a drug against septic shock that was developed through the company's Danish research center, which was about to begin phase 3 studies. That is how the industry is, says Ferring's Vice President in Denmark, who is now looking at drugs for fertility and pregnancy.

Marianne Kock, Vice President of Ferring Denmark, has pulled the plug on four year's work on a drug against septic shock. | Foto: Ferring

Swiss pharmaceutical company Ferring has scrapped a drug candidate in the late stages of development. The company's Danish research center was in charge of the drug candidate.

The company has dropped the drug Selepressin against septic shock - a critical level of blood poisoning - after the drug showed disappointing results in a phase 2b/3 study.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier